Treatment of diabetes insipidus in children with DDAVP, a synthetic analogue of vasopressin.
D000281:Administration, Intranasal; D000293:Adolescent; D001120:Arginine; D002648:Child; D002675:Child, Preschool; D003692:Delayed-Action Preparations; D003864:Depression, Chemical; D003919:Diabetes Insipidus / Q000188:drug therapy* / Q000652:urine; D004231:Diuresis / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005260:Female; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D009994:Osmolar Concentration; D013997:Time Factors; D014667:Vasopressins / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*
D003692:Delayed-Action Preparations; D014667:Vasopressins; D001120:Arginine